Clorox (NYSE:CLX) Price Target Raised to $95.00

Clorox (NYSE:CLX) had its target price upped by stock analysts at JPMorgan Chase & Co. from $92.00 to $95.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential downside of 8.96% from the company’s current price.

A number of other analysts have also recently commented on CLX. Wells Fargo & Company boosted their target price on shares of Clorox from $95.00 to $102.00 and gave the company an “equal weight” rating in a report on Tuesday. Royal Bank Of Canada lowered their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. Deutsche Bank Aktiengesellschaft set a $98.00 price objective on shares of Clorox in a report on Tuesday. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Finally, Evercore set a $99.00 target price on shares of Clorox in a report on Tuesday. Twelve equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $102.40.

Clorox Trading Up 6.2%

CLX stock traded up $6.09 during trading on Tuesday, reaching $104.35. The company had a trading volume of 3,131,043 shares, compared to its average volume of 2,545,055. The business has a 50 day moving average of $95.57 and a 200 day moving average of $103.57. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The company has a market cap of $12.62 billion, a P/E ratio of 16.88 and a beta of 0.54. Clorox has a 52 week low of $84.70 and a 52 week high of $128.90.

Clorox (NYSE:CLX) last announced its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.91 billion. During the same quarter in the prior year, the company earned $2.87 EPS. The business’s revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, sell-side analysts forecast that Clorox will post 5.52 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Clorox

A number of hedge funds have recently bought and sold shares of CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after acquiring an additional 514 shares during the last quarter. Woodline Partners LP boosted its holdings in Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after purchasing an additional 7,465 shares during the last quarter. Baird Financial Group Inc. lifted its holdings in shares of Clorox by 1.7% during the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after buying an additional 424 shares during the period. Jump Financial LLC lifted its holdings in shares of Clorox by 173.5% during the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after buying an additional 7,924 shares during the period. Finally, Bank of Nova Scotia boosted its stake in shares of Clorox by 26.2% in the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after buying an additional 3,352 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox reported fiscal Q4 adjusted earnings of $1.66 per share, topping the $1.64 consensus estimate, while revenue of $1.95 billion also exceeded expectations. The GOJO acquisition contributed roughly 10 percentage points to sales growth. Clorox Q4 Earnings and Sales Top Estimates as GOJO Supports Sales
• Positive Sentiment: Management projects fiscal 2027 sales growth of approximately 13% to 14%, supported by GOJO, easier enterprise-resource-planning comparisons, market-share recovery, pricing actions and improving demand in health, wellness and international markets. Adjusted EPS guidance is $5.70 to $6.00. Clorox Forecasts Upbeat Annual Sales as Demand Improves
• Positive Sentiment: Several analysts raised their Clorox price targets following the earnings beat. Wells Fargo lifted its target from $95 to $102 while maintaining an “equal weight” rating, signaling improved estimates but limited expected upside at current levels. Analysts Boost Forecasts on Clorox
• Neutral Sentiment: Clorox declared a quarterly dividend of $1.25 per share, up slightly from $1.24, with a reported annualized yield of about 5.2%. The dividend supports the stock’s income appeal but does not materially change the near-term earnings outlook.
• Negative Sentiment: Fiscal Q4 revenue declined 2% year over year, and fiscal 2026 sales fell 5% to $6.72 billion. Lower volumes, muted consumer categories, value-seeking shoppers and more than $200 million of anticipated inflation are expected to pressure margins and profitability. Clorox Outlines Inflation and Free Cash Flow Target
• Negative Sentiment: Fiscal 2026 EPS declined sharply from the prior year, while ERP implementation disruption and supply-chain costs continue to weigh on results. The optimistic sales forecast therefore comes with execution and margin risks.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.